# Pfizer clinical trials: 3,337 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 3,337 trials with Pfizer as lead sponsor, 142 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Pfizer: 3,337 rows for $113.37, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 13 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/pfizer

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 3,337
- Recruiting or not yet: 142
- Read on: November 19, 2026

## Trials

The 25 newest of 3,337, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07933848 | A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment | Pfizer | Phase 1 | Not yet recruiting | Renal Impairment, Healthy Adults | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933848) |
| November 12, 2026 | NCT07933835 | A Study to Learn How Different Amounts of the Study Medicine Called PF-08166744 Are Tolerated and Act in Healthy Adults. | Pfizer | Phase 1 | Not yet recruiting | Healthy Participants | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933835) |
| November 12, 2026 | NCT07932925 | The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or... | Pfizer | Phase 3 | Not yet recruiting | Urinary Incontinence, Stress, Overweight and/or Obesity | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932925) |
| November 9, 2026 | NCT07927023 | A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma | Pfizer | Observational | Not yet recruiting | Multiple Myeloma | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927023) |
| November 9, 2026 | NCT07923981 | A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors | Pfizer | Phase 3 | Recruiting | Hemophilia A or B | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923981) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 4, 2026 | NCT07915609 | A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2 | 756 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915609) |
| November 2, 2026 | NCT07909122 | Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic... | Pfizer | Observational | Not yet recruiting | Metastatic Colorectal Cancer | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909122) |
| October 30, 2026 | NCT07906262 | Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to... | Pfizer | Observational | Active not recruiting | Migraine | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906262) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 28, 2026 | NCT07900139 | A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026 | Pfizer | Observational | Active not recruiting | COVID-19 SARS-CoV-2 Infection | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900139) |
| October 27, 2026 | NCT07897721 | A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors | Pfizer | Phase 1 | Not yet recruiting | Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic... | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897721) |
| October 27, 2026 | NCT07897708 | A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older... | Pfizer | Phase 1 | Not yet recruiting | Alzheimer Disease | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897708) |
| October 27, 2026 | NCT07897669 | A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different... | Pfizer | Observational | Active not recruiting | Metastatic Urothelial Carcinoma, Urothelial Cancer, Urothelial Carcinoma, Locally Advanced or Metastatic Urothelial... | 5,122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897669) |
| October 22, 2026 | NCT07890597 | A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative... | Pfizer | Phase 3 | Not yet recruiting | Early Breast Cancer, Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) | 3,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890597) |
| October 21, 2026 | NCT07887867 | A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies | Pfizer | Observational | Not yet recruiting | Dermatitis, Atopic | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887867) |
| October 21, 2026 | NCT07885956 | A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults | Pfizer | Phase 3 | Not yet recruiting | Respiratory Syncytial Virus (RSV) | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885956) |
| October 19, 2026 | NCT07881835 | A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or... | Pfizer | Phase 4 | Not yet recruiting | Relapsed/Refractory Multiple Myeloma, Multiple Myeloma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881835) |
| October 19, 2026 | NCT07881757 | A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight... | Pfizer | Phase 3 | Recruiting | Apnea, Sleep Disorders, Overweight and/or Obesity | 258 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881757) |
| October 15, 2026 | NCT07876531 | A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or... | Pfizer | Phase 1 | Recruiting | Overweight and/or Obesity, Healthy Participants | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876531) |
| October 15, 2026 | NCT07876518 | A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity | Pfizer | Phase 1 | Not yet recruiting | Overweight and/or Obesity | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876518) |
| October 15, 2026 | NCT07874633 | A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight | 432 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874633) |
| October 9, 2026 | NCT07869043 | A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma | Pfizer | Phase 3 | Recruiting | Asthma | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869043) |
| October 5, 2026 | NCT07859527 | A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B | Pfizer | Observational | Recruiting | Hemophilia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859527) |
| September 29, 2026 | NCT07845513 | A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity | Pfizer | Phase 1 | Active not recruiting | Overweight, Obesity, Healthy Adults | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845513) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 2 |
| Phase 1 | 1,120 |
| Phase 1/2 | 65 |
| Phase 2 | 605 |
| Phase 2/3 | 40 |
| Phase 3 | 638 |
| Phase 4 | 221 |
| Not applicable | 75 |
| Observational | 571 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 2,507 |
| Terminated | 461 |
| Recruiting | 122 |
| Active not recruiting | 103 |
| Withdrawn | 101 |
| Not yet recruiting | 20 |
| No longer available | 14 |
| Available | 4 |
| Approved for marketing | 4 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 154 |
| Arthritis, Rheumatoid | 124 |
| Carcinoma, Non-Small-Cell Lung | 122 |
| Neoplasms | 80 |
| Diabetes Mellitus, Type 2 | 76 |
| Carcinoma, Renal Cell | 72 |
| COVID-19 | 67 |
| Alzheimer Disease | 63 |
| Pneumococcal Infections | 60 |
| Obesity | 60 |
| Pain | 58 |
| Dermatitis, Atopic | 57 |
| Colorectal Neoplasms | 52 |
| Migraine Disorders | 43 |
| Smoking Cessation | 43 |
| Neoplasm Metastasis | 42 |
| Lung Neoplasms | 41 |
| HIV Infections | 40 |
| Psoriasis | 39 |
| Melanoma | 38 |
| Colitis, Ulcerative | 37 |
| Hemophilia A | 35 |
| Multiple Myeloma | 35 |
| Acquired Immunodeficiency Syndrome | 33 |
| Prostatic Neoplasms | 33 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Thai restaurants in the United States](https://specstream.ai/data/businesses/thai-restaurants/united-states)
- [Breakfast and brunch restaurants in the United States](https://specstream.ai/data/businesses/breakfast-and-brunch-restaurants/united-states)
- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
- [Neurology practices in the United States](https://specstream.ai/data/businesses/neurology-practices/united-states)
- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
